Nabriva Therapeutics

Nabriva Therapeutics

Nabriva Therapeutics

Nabriva Therapeutics is a biopharmaceutical company focused on the R&D of antibiotics for use in community and hospital infections.
Founded
2001
Raised
$120M
Follow us
Alexa global traffic share
Latest funding
$120,000,000
Venture capital (Series B) - 2015
Team Size
1–10
Employees
Location
Headquarters
Acquisition
Xconomy

Nabriva Bolsters Antibiotics Pipeline with Zavante Acquisition

Health Strategy
VentureWire

Nabriva Therapeutics Amasses $120M for Drug to Treat Bacterial Pneumonia

Health Funding